KD Logo

Selling Buzz: Replimune Group Inc [REPL] Chief Medical Officer Xynos Konstantinos sells 7,246 shares of the company

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Replimune Group Inc shares valued at $78,112 were sold by Xynos Konstantinos on Nov 18 ’24. At $10.78 per share, Xynos Konstantinos sold 7,246 shares. The insider’s holdings dropped to 109,885 shares worth approximately $1.21 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Sarchi Christopher sold 5,207 shares, netting a total of over 56,131 in proceeds. Following the sale of shares at $10.78 each, the insider now holds 87,045 shares.

Before that, Hill Emily Luisa had sold 8,938 shares from its account. In a trade valued at $90,989, the Chief Financial Officer traded Replimune Group Inc shares for $10.18 each. Upon closing the transaction, the insider’s holdings decreased to 8,938 shares, worth approximately $1.12 million.

As published in their initiating research note from ROTH MKM on August 28, 2024, Replimune Group Inc [REPL] has been a Buy and the price target has been revised to $17. As of November 19, 2021, Piper Sandler has initiated its “an Overweight” rating for REPL.

Analyzing REPL Stock Performance

During the last five days, there has been a drop of approximately -3.07%. Over the course of the year, Replimune Group Inc shares have jumped approximately 31.08%. Shares of the company reached a 52-week high of $12.97 on 11/11/24 and a 52-week low of $4.92 on 05/29/24. A 50-day SMA is recorded $11.51, while a 200-day SMA reached $9.11. Nevertheless, trading volume fell to 0.74 million shares from 0.55 million shares the previous day.

Support And Resistance Levels for Replimune Group Inc (REPL)

According to the 24-hour chart, there is a support level at 10.92, which, if violated, would cause prices to drop to 10.78. In the upper region, resistance lies at 11.27. The next price resistance is at 11.49. RSI (Relative Strength Index) is 43.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.64, which suggests the price will decrease in the coming days. Percent R is at 80.00%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular